Skip to content

Expertise
How We Work
Insights
- Publications
- Blog
Company
- About
- Careers
- Contact Us

Blog September 20, 2015

Immuno-Oncology Brings New Opportunities for Developers of Targeted Cytotoxics

Share this Article

Facebook
Twitter
Linkedin
Email

Recent Articles

29 Aug 2023

Bionest

EU Proposes the First Pharmaceutical Legislation Reforms in Two Decades

EU Pharma legislation needs a makeover, but stakeholders disagree on the right approach. We look at the EC's long-anticipated proposals.

10 Jul 2023

Bionest

Reforming the Accelerated Approval Pathway

Will reforms to the FDA's Accelerated Approval process result in better compliance with confirmatory trial design, timing, and reporting?

26 Jun 2023

Bionest

Social Media Within the Healthcare Sector

Physicians and other healthcare providers have increasingly embraced social media to raise health awareness, combat misinformation and collaborate.

Home

We bring life sciences to life

Copyright © 2024 Bionest, part of Accenture.